Opioid use disorder: Flexible treatment at home proves effective

Infralow-frequency transcranial magnetic stimulation as a therapy for generalized anxiety disorder: A randomized trial finds that response rate was higher in the active group than in the sham group, with a significant difference at week 12 (response rate: 80.6% vs 54.8%, respectively; P = 0.03).

Mouse study shows gene therapy may correct creatine deficiency disorder

Removing barriers to opioid use disorder treatment shows success during pandemic